Re: Gardasil protects women, men from genital cancers

[Guest guest]

This is the biggest monster of all vaccinations.The harm is yet to be seen.

Google " truth about gardasil "

>

>

> Gardasil protects women, men from genital cancers

>

> In this Feb. 2, 2007 file photo, one dose of the vaccine Gardasil, developed

> by Merck & Co., is displayed in Austin, Texas. (AP Photo/Harry Cabluck,

> File)

>

> View Larger Image

>

> Font-size: Share Print

>

> a.. a.. Facebook

> b.. Twitter

> c.. DIGG

> d.. StumbleUpon

> e.. Newsvine

> f.. Reddit

> g.. delicious

> h.. Buzz

>

> The Associated Press

>

> Date: Wednesday Feb. 17, 2010 2:50 PM ET

>

> TRENTON, N.J. — The Gardasil vaccine protected most young women from

> cervical cancer and homosexual men from anal cancer, according to new

> studies released Wednesday by its maker, Merck & Co.

>

> The vaccine is designed to block four of the most common strains of the

> sexually transmitted human papilloma virus, or HPV. Two of those HPV strains

> cause the majority of cases of cervical cancer and anal cancer, and the

> other two can cause genital warts.

>

> Gardasil, Merck's top-selling vaccine, already is approved for prevention of

> cervical cancer and genital warts in girls and women aged nine to 26. It's

> also approved for preventing genital warts in boys and males aged nine to 26

> in the United States, however it has not been approved for use in men in

> Canada.

>

> Data from the new studies will be used to seek approval from the Food and

> Drug Administration to also market Gardasil for preventing cervical cancer

> and genital warts in women up to age 45 and for preventing anal cancer in

> males.

>

> Merck, which is based in Whitehouse Station, N.J., funded both studies.

>

> The women's study found three injections of the vaccine over six months

> prevented precancerous lesions on the cervix, as well as genital warts and

> persistent infections of HPV, in about 89 per cent of the participants,

> compared to women in a group that got three dummy shots. Altogether, 23

> women getting dummy shots and one getting the vaccine developed lesions or

> warts. That study included 3,819 24-to 45-year-old women, in multiple

> countries, who did not have cervical disease, genital warts or an HPV

> infection, which the immune system often eliminates over time. The women

> were examined periodically for about four years on average.

>

> The second study found three injections of the vaccine prevented anal cancer

> and precancerous lesions of the anus in about 77 per cent of young men,

> compared with those in a group getting dummy shots. No men in either group

> developed anal cancer, but 24 who got dummy shots and five who got the

> vaccine developed precancerous lesions. The men were studied for three years

> on average, starting with the first dose.

>

> The results were released early Wednesday, in conjunction with their

> presentation at a European conference of doctors and researchers

> specializing in cancer and genital infections.

>

> Merck submitted more detailed data from the women's study to the FDA late in

> 2009 and expects a ruling by June on whether it may market Gardasil for

> women aged 27 to 45. The regulatory agency previously turned Merck down,

> asking for longer-term follow-up on the women; this study followed them for

> an additional year and a half.

>

> The company plans to submit the data on anal cancer in men to the FDA and

> apply for approval to market the vaccine for that use at some point, said

> Merck spokeswoman Pam Eisele.

>

> Gardasil, one of Merck's 10 best-selling products, had sales totalling

> US$1.12 billion in 2009.

>

> Side effects of the vaccine include dizziness and fainting, nausea and

> vomiting, fever, headache and pain, swelling and itching at the injection

> site. Gardasil cannot be given to women who are pregnant or anyone with a

> severe allergy to yeast.

>

>

http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20100217/gardasil_vaccine_10\

0217/20100217?hub=Health

>